Aktiesnakken — Juli 2012
-
genmab aftalen blandt de 3 største i 10 år. Og vi ved jo allerede at arzerra også var blandt top 3 så det er faneme imponerende. http://medwatch.dk/secure/Medicinal___Biotek/article4780677.ece
-
læs lige den artikel
-
han markerer en del ting....
-
og der bliver lukket flere aftaler i den kommende tid.
-
det ser ud som om duobody faktisk har langt mere tyngde end jeg troede
-
jeg vil bate h
-
jeg vil bare have aftaler, penge i kassen og burn around!
-
carnegie køber stadigvæk
-
kig ikke på markedet, læs hvad han siger.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind